Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 3 pseudogene 14 (HMGB3P14) is a non-functional pseudogene derived from the HMGB3 gene[1][3][4]. Pseudogenes are sequence elements resembling functional genes but lack protein-coding ability due to accumulated mutations or truncations[2][3]. HMGB3P14 is annotated in the human genome; however, it does not produce a functional protein, participates in no recognized molecular pathways, nor does it have pharmacological significance as a therapeutic target[1][3][4]. There is no current evidence linking HMGB3P14 itself to specific biological processes or diseases. This entry is not a receptor, enzyme, transporter, transcription factor, or any actionable therapeutic target. It may occasionally be referred to in genome or bioinformatics databases, but its lack of function, regulatory impact, or disease association distinguishes it from protein-coding genes or druggable molecules[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 14 (HMGB3P14).